Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aveeno bath oil is a topical emollient bath additive manufactured by Johnson & Johnson, primarily used for the management of atopic dermatitis (eczema). It is formulated to support the skin's natural barrier by providing an occlusive layer that reduces transepidermal water loss and protects against external irritants. The product was a key intervention in the BATHE (Bath Additives for the Treatment of childhood Eczema) trial, a Phase 4 pragmatic randomized controlled trial conducted by the University of Southampton to assess the clinical and cost-effectiveness of bath additives in children. While the specific formulation includes ingredients like liquid paraffin and Avena sativa (oat) kernel oil, the BATHE trial notably found that the addition of such bath oils to standard eczema care provided no additional clinical benefit.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aveeno bath oil.